Benzoyl and/or benzyl substituted 1,2,3-triazoles as potassium channel activators. VIII

European Journal of Medicinal Chemistry

Volumn 40, Issue 6, 2005, Pages 521-528

  Calderone, Vincenzo ^a   Giorgi, Irene ^a   Livi, Oreste ^a   Martinotti, Enrica ^a   Mantuano, Elisabetta ^a   Martelli, Alma ^a   Nardi, Antonio ^a  

^a UNIVERSITY OF PISA   (Italy)

Author keywords

1,2,3 Triazoles; BK activators; Potassium channel openers; Potassium channels; Vasodilator activity

Indexed keywords

1 (2 HYDROXY 5 CHLOROBENZYL) 4 BENZOYL 1H 1,2,3 TRIAZOLE; 1 (2 HYDROXY 5 CHLOROBENZYL) 4 BENZYL 1H 1,2,3 TRIAZOLE; 1 (2 HYDROXY 5 CHLOROPHENYL) 4 BENZOYL 1H 1,2,3 TRIAZOLE; 1 (2 HYDROXY 5 CHLOROPHENYL) 4 BENZYL 1H 1,2,3 TRIAZOLE; 1 (2 HYDROXYBENZYL) 4 BENZOYL 1H 1,2,3 TRIAZOLE; 1 (2 HYDROXYBENZYL) 4 BENZYL 1H 1,2,3 TRIAZOLE; 1 (2 HYDROXYPHENYL) 4 BENZOYL 1H 1,2,3 TRIAZOLE; 1 (2 HYDROXYPHENYL) 4 BENZYL 1H 1,2,3 TRIAZOLE; 1,2,3 TRIAZOLE DERIVATIVE; [1 (5 CHLORO 2 HYDROXYPHENYL) 1H 1,2,3 TRIAZOL 4 YL]PHENYL KETONE OXIME; ACETYLENE DERIVATIVE; AZIDE; POTASSIUM CHANNEL STIMULATING AGENT; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; CONFORMATION; CYCLOADDITION; DRUG MECHANISM; DRUG SCREENING; DRUG STRUCTURE; DRUG SYNTHESIS; MALE; NONHUMAN; RAT; STRUCTURE ACTIVITY RELATION; VASODILATATION;

ANIMALS; AORTA; BENZOATES; BENZYL COMPOUNDS; LARGE-CONDUCTANCE CALCIUM-ACTIVATED POTASSIUM CHANNELS; MAGNETIC RESONANCE SPECTROSCOPY; MOLECULAR STRUCTURE; POTASSIUM CHANNELS, CALCIUM-ACTIVATED; RATS; STRUCTURE-ACTIVITY RELATIONSHIP; TRIAZOLES; VASODILATOR AGENTS;

EID: 19544383231     PISSN: 02235234     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejmech.2005.01.010     Document Type: Article

References (16)

1. V. Calderone Curr. Med. Chem. 9 2002 1385 1395
2. M.I. Coghlan, W.A. Carroll, and M. Gopalakrishnan J. Med. Chem. 44 2001 1627 1653
3. G. Biagi, V. Calderone, I. Giorgi, O. Livi, E. Martinotti, A. Martelli, and A. Nardi Farmaco 59 2004 397 404
4. S.P. Olesen, E. Munch, P. Moldt, and J. Drejer Eur. J. Pharmacol. 251 1994 53 59
5. V. Calderone, I. Giorgi, O. Livi, E. Martinotti, A. Martelli, Nardi, Farmaco (2005) in press.
6. Y. Li, G. Johnson, J.L. Romine, N.A. Meanwell, S.W. Martin, S.I. Dworetzky, C.G. Boissard, V.K. Gribkoff, and J.E. Starrett Jr. Bioorg. Med. Chem. Lett. 13 2003 1437 1439
7. B.C. Ranu, A. Sarkar, and R. Chakraborty J. Org. Chem. 59 1994 4114 4116
8. K. Bowden, J.M. Heilbron, E.R.H. Jones, and B.C.L. Weedon J. Chem. Soc. 1946 39 45
9. Y. Kita, H. Tohma, K. Hatanaka, T. Takada, S. Fujjita, S. Mitoh, H. Sakurai, and S. Oka J. Am. Chem. Soc. 116 1994 3684 3691
10. G. Biagi, M. Ferretti, O. Livi, V. Scartoni, A. Lucacchini, and M. Mazzoni Farmaco 41 1986 388 400
11. G. Biagi, I. Giorgi, O. Livi, A. Lucacchini, C. Martini, and V. Scartoni J. Pharm. Sci. 82 1993 893 896
12. T.L. Gilchrist, and G.E. Gymer 1,2,3-Triazoles A.R. Katritzky A.J. Boulton Advances in Heterocyclic Chemistry 1974 Academic Press, New York, London 33 85 vol. 16
13. P.L. Ferrarini, and O. Livi Farmaco 33 1978 543 550
14. G. Biagi, O. Livi, and V. Scartoni Farmaco 42 1987 285 297
15. I.C. Barrett, J.D. Langille, and M.A. Kerr J. Org. Chem. 65 2000 6268 6269
16. J. Malysz, S.A. Buckner, A.V. Daza, I. Milicic, A. Perez-Medrano, and M. Gopalakrishnan Naunyn Schmiedebergs Arch. Pharmacol. 369 2004 481 489